samedan logo
 
 
spacer
home > pmps > winter 2020 > the economy or the environment?
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Economy or the Environment?



PMPS: What are the main practical issues/challenges related to green supply chains?

Jason Hibbs: I think the problem logistics as a whole faces is that a supply chain inherently uses resources: manufacturing, packaging, warehousing, transport, reverse logistics, and the people to achieve all of that. This is unavoidable if people want goods delivered cheaply with ever increasing customer service expectations; however, I don’t think the politicians and campaigners for a greener planet have really thought this through.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Jason Hibbs is Managing Director of Jet Environmental, the specialist provider and installer of energy-efficient heating, ventilation, and cooling systems for large volume, open plan spaces. Responsible for the company’s three divisions, Jet Environmental, Jet Maintain, and Outsourced Air, Jason manages growth strategies and leads technical development processes. He is the first point of contact for clients and new business prospects. A key part of his role is to listen to every client’s individual needs before proposing a best practice, cost-effective solution. Jason brings accuracy, thoroughness, and integrity to his dealings with colleagues and customers.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Winners of the 2021 CPhI Pharma Awards have now been announced

Milan, 10 November 2021: CPhI Worldwide announces the winners of the 18th edition of the CPhI Pharma Awards, hosted live in Milan, with winners spanning some 10 distinct categories. The Awards seek to recognise ‘Excellence in Pharma’ , assessing entries from the industry leading companies and individuals.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement